FDA Adverse Event Injury Summary report: N

SQ-RX PULSE GENERATOR

MDR report key: 21963616 · Received May 5, 2025

Report

Report Number
2124215-2025-28693
Event Type
Injury
Date Received
May 5, 2025
Date of Event
December 5, 2023
Report Date
May 5, 2025
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

HORI, YUICHI, ET AL. (2024). IMPORTANCE OF VISUALIZING THE ANATOMICAL LOCATION OF THE LATISSIMUS DORSI MUSCLE USING COMPUTED TOMOGRAPHY FOR A ROBUST REIMPLANTATION OF A SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR. JOURNAL OF CARDIOLOGY CASES 30 (2024) 147-149. HTTPS://DOI.ORG/10.1016/J.JCCASE.2024.07.003. DETAILED PRODUCT INFORMATION WAS NOT PROVIDED TO BSC. WE COMPLETED A GOOD FAITH EFFORT TO OBTAIN THE INFORMATION. BECAUSE THE PRODUCT IS UNKNOWN AT THIS TIME, WE ARE UNABLE TO PROVIDE THE COMPLETE UNIQUE IDENTIFIER (UDI) # AND OTHER SPECIFIC PRODUCT INFORMATION. IF ADDITIONAL DETAILS BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 0

IT WAS REPORTED PER ARTICLE OF INTEREST LITERATURE REVIEW THAT THE AUTHORS USED THE SUBMUSCULAR APPROACH HAS BEEN USED AS AN ALTERNATIVE TECHNIQUE FOR THE IMPLANT POSITION OF A SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (S-ICD). AN S-ICD MIGRATED AND CAUSED THE PATIENTS SKIN TO THIN, WITH THE PATIENT EXPERIENCING PAIN AS A RESULT. A CHEST COMPUTED TOMOGRAPHY (CT) SCAN WAS PERFORMED AND THE DEVICE WAS REPOSITIONED. AFTERWARDS, A DEFIBRILLATION THRESHOLD (DFT) TEST WAS PERFORMED SUCCESSFULLY. ADDITIONALLY, A CT SCAN AND X-RAY IMAGING WERE PERFORMED AFTER THE REVISION TO VERIFY THE S-ICD POSITION. THIS S-ICD REMAINS IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
443635 SQ-RX PULSE GENERATOR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT) LWS BOSTON SCIENTIFIC CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 70 YR Unknown Required Intervention| H